Showing results (1041-1050 of 1,907) with videos related to
Sort By:
Pageof 191
The American Journal of Medicine|January 1, 1986
Primary Sjögren's syndrome in men. Clinical, serologic, and immunogenetic featuresR Molina, T T Provost, F C Arnett, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 1, 1989
Estrogen receptors and human bone cells: immunocytochemical studiesK W Colston, R J King, J Hayward, et al.Journal of the American Chemical Society|December 14, 2016
Copper Catalyzed sp3 C-H Etherification with Acyl Protected PhenolsTolani K Salvador, Charles H Arnett, Subrata Kundu, et al.Stroke|August 1, 1994
Relations of intimal-medial thickness among sites within the carotid artery as evaluated by B-mode ultrasound. ARIC Investigators. Atherosclerosis Risk in CommunitiesG Howard, G L Burke, G W Evans, et al.Genes and Immunity|July 31, 2001
Glutathione S-transferase genotypes in systemic sclerosis and their association with clinical manifestations in early diseaseM B Tew, J D Reveille, F C Arnett, et al.Inflammatory Bowel Diseases|November 15, 2011
Matriptase protects against experimental colitis and promotes intestinal barrier recoverySarah Netzel-Arnett, Marguerite S Buzza, Terez Shea-Donohue, et al.Preventive Medicine|March 12, 1999
Physical activity and incident hypertension in black and white adults: the Atherosclerosis Risk in Communities StudyM A Pereira, A R Folsom, P G McGovern, et al.Science (New York, N.Y.)|September 30, 1983
Carbocyclic arabinofuranosyladenine (cyclaradine): efficacy against genital herpes in guinea pigsR Vince, S Daluge, H Lee, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 21, 2012
Clopidogrel (Plavix), a P2Y12 receptor antagonist, inhibits bone cell function in vitro and decreases trabecular bone in vivoSusanne Syberg, Andrea Brandao-Burch, Jessal J Patel, et al.International Journal of Rheumatology|July 31, 2012
Markers of treatment response to methotrexate in rheumatoid arthritis: where do we stand?Karina I Halilova, Elizabeth E Brown, Sarah L Morgan, et al.Pageof 191